A multimodal defect-rich nanoreactor triggers sono-piezoelectric tandem catalysis and iron metabolism disruption for implant infections
Tracking and eradicating drug-resistant bacteria are critical for combating implant-associated infections, yet effective antibacterial therapies remain elusive. Herein, we propose an oxygen vacancy-rich (BiFe)<sub>0.9</sub>(BaTi)<sub>0.1</sub>O<sub>3-</sub><sub><i>x</i></sub> nanoreactor as a piezoelectric sonosensitizer by spatiotemporal ultrasound-driven sono- and chemodynamic tandem catalysis to amplify antibacterial efficacy. The piezoelectric charge carriers under a built-in electric field synchronize the reaction of O<sub>2</sub> and H<sub>2</sub>O, efficiently generating H<sub>2</sub>O<sub>2</sub>. The electron-rich oxygen vacancies modulate the local electronic structure of an Fe site. It facilitates reactive oxygen species generation by piezoelectric electrons and accelerates valence state cycles of Fe(III)/Fe(II) to achieve the sustained maintenance of hydroxyl radicals via H<sub>2</sub>O<sub>2</sub>/Fe(II)-catalyzed chemodynamic reactions, which lead to bacterial membrane damage. Transcriptomics analysis revealed that intracellular Fe overload induced by excessive Fe(II)-mediated dysregulation of the two-component system disrupts bacterial metabolism, triggering bacterial ferroptosis-like death. Thus, the porous titanium scaffold, engineered with a piezoelectric nanoreactor, demonstrates superior antibacterial efficacy under ultrasound and facilitates osteogenesis via piezoelectric immunomodulation-activated therapy.
Authors
- Jiagang Wu (ORCID: https://orcid.org/0000-0002-9960-9275)
- Qiaochu Li (ORCID: https://orcid.org/0000-0001-8032-9110)
- Hong Xu (ORCID: https://orcid.org/0000-0001-6666-9805)
- Duan Wang (ORCID: https://orcid.org/0000-0001-5487-4414)
- Xin Tang (ORCID: https://orcid.org/0000-0002-5056-124X)
- Qiang Su (ORCID: https://orcid.org/0000-0003-1433-3407)
- Xiang Lv (ORCID: https://orcid.org/0000-0001-6101-7568)
- Shuoyuan Li (ORCID: https://orcid.org/0009-0006-0050-2870)
- Fuyuan Zheng (ORCID: https://orcid.org/0000-0003-0485-2422)
- Yangming Zhang (ORCID: https://orcid.org/0000-0002-2076-1013)
- Jian Li (ORCID: https://orcid.org/0000-0002-6223-9493)
- Zhuang Zhang (ORCID: https://orcid.org/0000-0002-3834-3477)
- Xiao Yang (ORCID: https://orcid.org/0000-0001-7248-8218)
- Jian Cao (ORCID: https://orcid.org/0000-0003-4299-9484)
- Zongke Zhou (ORCID: https://orcid.org/0000-0001-8091-0474)
- Le Tong (ORCID: https://orcid.org/0000-0002-4861-4787)
- Long Zhao (ORCID: https://orcid.org/0000-0002-6025-9941)
- X. Chen (ORCID: https://orcid.org/0000-0002-1372-429X)
- Xufeng Wan (ORCID: https://orcid.org/0009-0004-6477-5048)
- Yan Yue (ORCID: https://orcid.org/0009-0003-1226-1646)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Mianyang Third People's Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Science Advances
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1126/sciadv.ads8694
- Citations
- 28
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 18.88